Viewing Study NCT00153023


Ignite Creation Date: 2025-12-18 @ 8:15 AM
Ignite Modification Date: 2025-12-18 @ 8:15 AM
Study NCT ID: NCT00153023
Status:
Last Update Posted:
First Post:
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: 1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy
Sponsor:
Organization:

Study Modules

Contacts Locations Module Design Module Eligibility Module Outcomes Module